BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 19047354)

  • 41. Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model.
    Mihu MR; Cabral V; Pattabhi R; Tar MT; Davies KP; Friedman AJ; Martinez LR; Nosanchuk JD
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short communication: Effects of lactose and milk on the expression of biofilm-associated genes in Staphylococcus aureus strains isolated from a dairy cow with mastitis.
    Xue T; Chen X; Shang F
    J Dairy Sci; 2014 Oct; 97(10):6129-34. PubMed ID: 25151886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biofilm formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model.
    Fluckiger U; Ulrich M; Steinhuber A; Döring G; Mack D; Landmann R; Goerke C; Wolz C
    Infect Immun; 2005 Mar; 73(3):1811-9. PubMed ID: 15731082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies.
    Schilcher K; Horswill AR
    Microbiol Mol Biol Rev; 2020 Aug; 84(3):. PubMed ID: 32792334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Small Molecules Produced by Commensal Staphylococcus epidermidis Disrupt Formation of Biofilms by Staphylococcus aureus.
    Glatthardt T; Campos JCM; Chamon RC; de Sá Coimbra TF; Rocha GA; de Melo MAF; Parente TE; Lobo LA; Antunes LCM; Dos Santos KRN; Ferreira RBR
    Appl Environ Microbiol; 2020 Feb; 86(5):. PubMed ID: 31862721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced production of exopolysaccharide matrix and biofilm by a menadione-auxotrophic Staphylococcus aureus small-colony variant.
    Singh R; Ray P; Das A; Sharma M
    J Med Microbiol; 2010 May; 59(Pt 5):521-527. PubMed ID: 20110391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Staphylococcus aureus Fibronectin Binding Protein A Mediates Biofilm Development and Infection.
    Gries CM; Biddle T; Bose JL; Kielian T; Lo DD
    Infect Immun; 2020 Apr; 88(5):. PubMed ID: 32041788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The major autolysin is redundant for Staphylococcus aureus USA300 LAC JE2 virulence in a murine device-related infection model.
    McCarthy H; Waters EM; Bose JL; Foster S; Bayles KW; O'Neill E; Fey PD; O'Gara JP
    FEMS Microbiol Lett; 2016 May; 363(9):. PubMed ID: 27044299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A simple surface biofunctionalization strategy to inhibit the biofilm formation by Staphylococcus aureus on solid substrates.
    Martín ML; Dassie SA; Valenti LE; Giacomelli CE
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110432. PubMed ID: 31421403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanoscale Plasma Coating Inhibits Formation of Staphylococcus aureus Biofilm.
    Xu Y; Jones JE; Yu H; Yu Q; Christensen GD; Chen M; Sun H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7308-15. PubMed ID: 26369955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections.
    Rohde H; Burandt EC; Siemssen N; Frommelt L; Burdelski C; Wurster S; Scherpe S; Davies AP; Harris LG; Horstkotte MA; Knobloch JK; Ragunath C; Kaplan JB; Mack D
    Biomaterials; 2007 Mar; 28(9):1711-20. PubMed ID: 17187854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine.
    Cerca N; Jefferson KK; Maira-Litrán T; Pier DB; Kelly-Quintos C; Goldmann DA; Azeredo J; Pier GB
    Infect Immun; 2007 Jul; 75(7):3406-13. PubMed ID: 17470540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Poly-N-acetylglucosamine is not a major component of the extracellular matrix in biofilms formed by icaADBC-positive Staphylococcus lugdunensis isolates.
    Frank KL; Patel R
    Infect Immun; 2007 Oct; 75(10):4728-42. PubMed ID: 17635864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Staphylococcus aureus glucose-induced biofilm accessory proteins, GbaAB, influence biofilm formation in a PIA-dependent manner.
    You Y; Xue T; Cao L; Zhao L; Sun H; Sun B
    Int J Med Microbiol; 2014 Jul; 304(5-6):603-12. PubMed ID: 24836943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase variation of poly-N-acetylglucosamine expression in Staphylococcus aureus.
    Brooks JL; Jefferson KK
    PLoS Pathog; 2014 Jul; 10(7):e1004292. PubMed ID: 25077798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A mouse model of Staphylococcus catheter-associated biofilm infection.
    Heim CE; Hanke ML; Kielian T
    Methods Mol Biol; 2014; 1106():183-91. PubMed ID: 24222467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
    Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
    BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel Treatment of Staphylococcus aureus Device-Related Infections Using Fibrinolytic Agents.
    Hogan S; O'Gara JP; O'Neill E
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biofilm formation and dispersal of Staphylococcus aureus under the influence of oxacillin.
    Mirani ZA; Aziz M; Khan MN; Lal I; Hassan NU; Khan SI
    Microb Pathog; 2013; 61-62():66-72. PubMed ID: 23711963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl beta-1,6 glucosamine specific antibody production using biofilm-embedded bacteria.
    Pérez MM; Prenafeta A; Valle J; Penadés J; Rota C; Solano C; Marco J; Grilló MJ; Lasa I; Irache JM; Maira-Litran T; Jiménez-Barbero J; Costa L; Pier GB; de Andrés D; Amorena B
    Vaccine; 2009 Apr; 27(17):2379-86. PubMed ID: 19428854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.